Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김동혁 | * |
dc.date.accessioned | 2020-12-07T16:30:02Z | - |
dc.date.available | 2020-12-07T16:30:02Z | - |
dc.date.issued | 2020 | * |
dc.identifier.issn | 2045-2322 | * |
dc.identifier.other | OAK-28161 | * |
dc.identifier.uri | https://dspace.ewha.ac.kr/handle/2015.oak/255612 | - |
dc.description.abstract | Atrial remodeling with fibrosis has been well-described in patients with atrial fibrillation (AF). We hypothesized that the left atrial (LA)-late gadolinium enhancement (LGE) extent on cardiac magnetic resonance (CMR) imaging is associated with LA pressure and can be a marker for suitable candidates for non-paroxysmal AF ablation. A total of 173 AF patients with an LA-LGE area on CMR imaging were enrolled. The clinical parameters, including invasively measured LA pressure, were compared between the patients with extensive LA-LGE (E-LGE, LGE extent ≥ 20%, n = 78) and those with small LA-LGE (S-LGE, LGE extent < 20%, n = 95). The E-LGE group had higher peak LA pressures than the S-LGE group (23 versus 19 mmHg, p < 0.001). The E-LGE group had more patients with non-paroxysmal AF (non-PAF) (51% vs. 34%), heart failure (9% vs. 0%), and higher NT pro-B-type natriuretic peptide (472 vs. 265 pg/ml) (all p < 0.05). LA pressure ≥ 21 mmHg was an independent predictor of E-LGE (OR = 2.218; p = 0.019). In the paroxysmal AF (PAF) subgroup, freedom from atrial arrhythmia after catheter ablation was not different (81% vs 86%, log-rank p = 0.529). However, in the non-PAF subgroup, it was significantly higher in the S-LGE group than in the E-LGE group (81% vs 55%, log-rank p = 0.014). Increased LA pressure was related to the LA-LGE extent. LA-LGE was a good predictor of outcome after catheter ablation, but only in patients with non-PAF. © 2020, The Author(s). | * |
dc.language | English | * |
dc.publisher | Nature Research | * |
dc.title | Association of left atrial pressure with late gadolinium enhancement extent in patient who underwent catheter ablation for atrial fibrillation | * |
dc.type | Article | * |
dc.relation.issue | 1 | * |
dc.relation.volume | 10 | * |
dc.relation.index | SCIE | * |
dc.relation.index | SCOPUS | * |
dc.relation.journaltitle | Scientific Reports | * |
dc.identifier.doi | 10.1038/s41598-020-72929-0 | * |
dc.identifier.wosid | WOS:000577289200001 | * |
dc.identifier.scopusid | 2-s2.0-85091986657 | * |
dc.author.google | Roh S.-Y. | * |
dc.author.google | Lee D.I. | * |
dc.author.google | Hwang S.H. | * |
dc.author.google | Lee K.-N. | * |
dc.author.google | Baek Y.-S. | * |
dc.author.google | Iqbal M. | * |
dc.author.google | Kim D.-H. | * |
dc.author.google | Ahn J. | * |
dc.author.google | Shim J. | * |
dc.author.google | Choi J.-I. | * |
dc.author.google | Kim Y.-H. | * |
dc.contributor.scopusid | 김동혁(55642581600;57224891671) | * |
dc.date.modifydate | 20240426132019 | * |